Analysis of giant cell tumour of bone cells for Noonan syndrome/Cherubism‐related mutations
- 22 June 2012
- journal article
- research article
- Published by Wiley in Journal of Oral Pathology & Medicine
- Vol. 42 (1) , 95-98
Abstract
Background: Giant cell tumour of bone (GCTB) is an osteolytic tumour which contains numerous osteoclast‐like giant cells and a proliferation of mononuclear stromal cells (MSC). Giant cell‐rich osteolytic lesions can also develop in the jaw bones in Noonan syndrome, a cherubism‐like developmental abnormality that is transmitted in an autosomal dominant fashion, often because of mutation in the PTPN11 or BRAF genes.Methods: We screened GCTBs for mutations in PTPN11 and BRAF to determine whether GCTBs develop through alterations of genes involved in Noonan syndrome. MSC were isolated from 10 GCTBs.Results: Chromosome banding analysis of these cells revealed telomeric associations (tas) in 7 of the 10 cases. Thus, the cultured cells expressed a cytogenetic abnormality typically found in short‐term cultures from GCTBs. Sequencing of DNA extracted from the seven GCTB‐derived MSC cultures displaying tas did not identify any mutation in PTPN11 or in exons 9–15 of BRAF.Conclusion: Our findings indicate that the molecular pathways involved in GCTB development are different from those causing Noonan syndrome. The method for isolating and culturing GCTB stromal cells described in this study generated a population of MSC that contained tas, indicating that it is useful for obtaining stromal cells from GCTB and other giant cell‐rich lesions, such as giant cell reparative granuloma, for genetic and other studies.Keywords
This publication has 29 references indexed in Scilit:
- Noonan Syndrome: Clinical Aspects and Molecular PathogenesisMolecular Syndromology, 2010
- Genomic instability in giant cell tumor of bone. A study of 52 cases using DNA ploidy, relocalization FISH, and array‐CGH analysisGenes, Chromosomes and Cancer, 2009
- Mutations in SH3BP2, the cherubism gene, were not detected in central or peripheral giant cell tumours of the jawBritish Journal of Oral and Maxillofacial Surgery, 2008
- Cardio-facio-cutaneous and Noonan syndromes due to mutations in the RAS/MAPK signalling pathway: genotype phenotype relationships and overlap with Costello syndromeJournal of Medical Genetics, 2007
- SH3BP2 Is Rarely Mutated in Exon 9 in Giant Cell Lesions Outside CherubismClinical Orthopaedics and Related Research, 2007
- Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndromeNature Genetics, 2006
- Neurofibromatosis presenting with a cherubism phenotypeEuropean Journal of Pediatrics, 2006
- Identification of a novel mutation ofSH3BP2in cherubism and demonstration thatSH3BP2mutations lead to increased NFAT activationHuman Mutation, 2006
- Noonan‐like syndrome mutations in PTPN11 in patients diagnosed with cherubismClinical Genetics, 2005
- Clinicopathologic study of 24 cases of cherubismInternational Journal of Oral and Maxillofacial Surgery, 2005